Related Experiment Video

Updated: Apr 10, 2026

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

818

Oncoleaking: Use of the Pore-Forming Clostridium perfringens Enterotoxin (CPE) for Suicide Gene Therapy

Jessica Pahle1, Jutta Aumann, Dennis Kobelt

  • 1Experimental and Clinical Research Center (ECRC), Charité University Medicine Berlin, Berlin, Germany.

Methods in Molecular Biology (Clifton, N.J.)
|June 15, 2015
PubMed

Insights

Bacterial Clostridium perfringens enterotoxin (CPE) offers a novel suicide gene therapy approach. This pore-forming protein specifically targets and kills cancer cells overexpressing claudins, showing promise for refractory tumors.

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • Suicide gene therapy is effective for tumor eradication.
  • Ongoing research aims to improve cancer gene therapy targeting and efficacy.
  • Bacterial toxins represent a promising alternative for suicide gene strategies.

Purpose of the Study:

  • To introduce Clostridium perfringens enterotoxin (CPE) as a novel suicide gene therapy agent.
  • To evaluate the potential of CPE-expressing vectors for targeting claudin-overexpressing cancers.
  • To explore CPE as a strategy for treating therapy-refractory tumors.

Main Methods:

  • Generation of CPE-expressing vectors.
  • In vitro and in vivo testing of CPE's efficacy.
  • Assessment of CPE's toxicity towards cancer cells.

Main Results:

  • CPE acts as a pore-forming protein, inducing rapid and specific toxicity.
  • CPE effectively targets cancer cells overexpressing claudin-3 and claudin-4.
  • CPE-expressing vectors demonstrate potential for tumor cell killing.

Conclusions:

  • Claudin-targeted CPE is a viable novel suicide gene therapy approach.
  • CPE shows significant potential for treating therapy-refractory cancers.
  • This strategy offers a new avenue in cancer gene therapy development.

More Related Videos

Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans07:32

Biolistic Transformation of a Fluorescent Tagged Gene into the Opportunistic Fungal Pathogen Cryptococcus neoformans

Published on: March 19, 2015

10.7K
Producing Gene Deletions in Escherichia coli by P1 Transduction with Excisable Antibiotic Resistance Cassettes08:13

Producing Gene Deletions in Escherichia coli by P1 Transduction with Excisable Antibiotic Resistance Cassettes

Published on: September 1, 2018

18.2K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.2K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
7.4K